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Background: Cancer detection using sniffer dogs is a potential technology for clinical use and research. Our study
sought to determine whether dogs could be trained to discriminate the odour of urine from men with prostate
cancer from controls, using rigorous testing procedures and well-defined samples from a major research hospital.
Methods: We attempted to train ten dogs by initially rewarding them for finding and indicating individual prostate
cancer urine samples (Stage 1). If dogs were successful in Stage 1, we then attempted to train them to discriminate
prostate cancer samples from controls (Stage 2). The number of samples used to train each dog varied depending
on their individual progress. Overall, 50 unique prostate cancer and 67 controls were collected and used during
training. Dogs that passed Stage 2 were tested for their ability to discriminate 15 (Test 1) or 16 (Tests 2 and 3)
unfamiliar prostate cancer samples from 45 (Test 1) or 48 (Tests 2 and 3) unfamiliar controls under double-blind
conditions.
Results: Three dogs reached training Stage 2 and two of these learnt to discriminate potentially familiar prostate
cancer samples from controls. However, during double-blind tests using new samples the two dogs did not indicate
prostate cancer samples more frequently than expected by chance (Dog A sensitivity 0.13, specificity 0.71, Dog B
sensitivity 0.25, specificity 0.75). The other dogs did not progress past Stage 1 as they did not have optimal
temperaments for the sensitive odour discrimination training.
Conclusions: Although two dogs appeared to have learnt to select prostate cancer samples during training, they
did not generalise on a prostate cancer odour during robust double-blind tests involving new samples. Our study
illustrates that these rigorous tests are vital to avoid drawing misleading conclusions about the abilities of dogs to
indicate certain odours. Dogs may memorise the individual odours of large numbers of training samples rather than
generalise on a common odour. The results do not exclude the possibility that dogs could be trained to detect
prostate cancer. We recommend that canine olfactory memory is carefully considered in all future studies and
rigorous double-blind methods used to avoid confounding effects.
Keywords: Prostate cancer, Cancer detection dogs, Cancer odour, Olfactory memory, Multiple sample learning* Correspondence: Hywel.Williams@nottingham.ac.uk
4Centre of Evidence-based Dermatology, Nottingham University Hospitals NHS
Trust, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH,
UK
Full list of author information is available at the end of the article
© 2014 Elliker et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Elliker et al. BMC Urology 2014, 14:22 Page 2 of 9
http://www.biomedcentral.com/1471-2490/14/22Background
Due to the high sensitivity and selectivity of the canine
olfactory system and the relative ease with which dogs
can be trained and handled, working dogs have been
routinely used for decades as the primary means to de-
tect a wide range of substances in environments that
contain complex background odours. It has long been
suspected that dogs can recognise certain aspects of hu-
man body odour. For example, bloodhounds have been
used for centuries to track specific people starting from
a trace of body odour on an item [1] and dogs have been
trained to discriminate individual people by their scent
[2,3]. However, it is only relatively recently that investi-
gations have begun to explore the utility of detection
dogs for medical diagnostic purposes, for diseases such
as epilepsy [4], diabetes [5] and cancer [6-13].
The use of dogs for cancer detection is a particularly
interesting technology because diagnostic methods for
some cancers could be improved [14] and reliable, cost-
effective, non-invasive methods of mass-screening for
diseases such as prostate cancer would be valuable. It
has been suggested that some forms of cancer emit de-
tectable odours [15] and there are cases in which dogs
have used olfaction to spontaneously alert their owners
to what later proved to be a malignant lesion [6,7]. In
one case involving breast cancer, a dog showed renewed
olfactory interest some months after the tumour had
been removed and a recurrent lesion was discovered in
the scar tissue at the site of the operation (Sommerville
and Church, personal communication). After treatment,
the dog again lost interest.
Several studies have reported that it is possible to train
dogs to detect or discriminate odours on the basis of
cancer: bladder cancer [8], skin melanoma [9], lung cancer
[10], breast cancer [10,11] and ovarian cancer [12]. How-
ever, research is at an early stage in elucidating how dogs
learn these discrimination tasks and determining the best
way to train them in order to produce a reliable screening
capability. A review of methods and accuracy of studies to
date [16] highlighted that many of these studies have yet
to be fully optimised. Shortcomings have included: lack of
age-matched controls potentially causing confounding of
age with disease; not reporting whether an independent
observer was present or a data audit completed; pseudo-
replication of samples during testing, potentially making
them familiar to the dogs.
The studies of canine cancer detection that have been
conducted to date suggest that dogs can sometimes gener-
alise and indicate a common cancer odour when trained
with a range of samples from different donors. However, an
important question is whether a potentially limited hospital
supply of cancer and control samples from new, unique
donors would be sufficient to train and maintain a gen-
eralised cancer detection capability.Our study therefore aimed to test whether it is possible
to train dogs to indicate an odour associated with prostate
cancer in human urine, using the maximum number of
training samples available from a major research hospital.
We aimed to use an optimised and rigorously controlled
design to rule out any possible sources of bias.
Methods
Animals
Ten dogs of seven different breeds (1–11 years old, four
females and six males) were initially recruited from a pool
of dogs attending classes at a dog training centre. This
selection was based on the professional opinion of dog
trainers or behavioural scientists, who had trained or ob-
served the dogs during activities such as agility, obedience,
gun-dog work, or location and retrieval of items for their
owners. The dogs had not previously been used in scien-
tific odour discrimination work. Further down-selection
based on the dogs’ abilities to detect odours was carried
out in the training stages (see Training procedure). All dogs
were handled by professional dog trainers or behavioural
scientists during the training and testing sessions and were
cared for by their owners between sessions.
Urine sample collection and preparation
Urine samples were collected and prepared, with the
donors’ permission, in the Department of Oncology,
Addenbrooke’s Hospital, UK. All samples were collected
using the same protocols, at the same locations and by
the same research team to ensure they had the same
general background odour. The age, Prostate Specific
Antigen (PSA) measurement, urinalysis, Gleason Test score
(when obtained) and medical history were recorded.
In total, 50 prostate cancer (CaP) samples and 67 control
samples from different individuals were collected and used
over the course of the dog training period. CaP samples
were collected from donors with prostate cancer that had
been previously confirmed by biopsy but remained un-
treated. The degree of disease in CaP donors varied from
small, relatively innocent tumours to metastasised cancer.
Control samples were collected from men with Benign
Prostatic Hyperplasia (BPH – a benign enlargement of the
prostate), as well as 10 healthy men without clinical symp-
toms. Fifty-two controls had PSA levels <0.5 ng/ml, two
had PSA <1.5 ng/ml and seven had PSA between 2.2 and
11.6 ng/ml. Thirteen of these controls, including all with
PSA >2.2 ng/ml, had previously undergone prostate biopsy
with negative results. Donors were excluded from the CaP
group if they presented with frank haematuria or urinary
tract infection, from the control group in the case of un-
certain diagnosis and from both groups if they suffered
from a current, non-prostatic cancer. CaP and control
sample pools were chosen that were as similarly aged as
was feasible based on the available urine donors.
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were used in Test 1 and 16 CaP and 48 controls in Tests 2
and 3 (Table 1). All control donors used in tests had a
PSA <0.5 ng/ml. Overall mean donor ages in Test 1 were
64.1 years (standard deviation = 8.3) for CaP and 58.3 years
(standard deviation = 6.6) for control. For Tests 2 and 3 the
overall mean ages were 63.6 years (standard deviation = 6.4)
for CaP and 57.7 years (standard deviation = 5.2) for con-
trol. The range of donor age differences between the CaP
and control samples presented to the dogs in each array
was: 34.5% of control samples within ± 5 years of the CaP,
28.6% within ± 10 years, 32.1% within ± 20 years and 4.8%
± 20 years or more. All samples were taken from different
individuals, had not previously been presented to the dog
and were presented only once during each test.
Urine samples were collected in 50 ml polypropylene
screw-cap tubes and frozen at −20°C within 10 minutes.
Samples were transported to the testing centre on dry
ice, defrosted in a 37°C water bath, aliquoted into 1.5 ml
polypropylene micro-centrifuge tubes and stored in a
freezer at −20°C. Samples were generally stored for 1 to
60 days prior to presentation to the dogs, though some
were stored for up to 6 months. During training or testing,
1 ml aliquots were heated to 37°C in a water bath and then
presented to the dogs in new open-top, polypropylene
test tubes.
Experimental setup
Dogs were trained in a 6 m × 10 m rubber-floored arena
(Figure 1). Urine samples were presented in four,
90 mm-deep aluminium flasks recessed into a 3 m long
floor-mounted plastic array. The urine was not visible
or accessible to the dogs other than by olfaction through
four, 20 mm-diameter ‘scent holes’, spaced 0.75 m apart, po-
sitioned directly above each flask. These holes were labelled
above with numbers. To prevent cross-contamination,
the investigator wore nitrile gloves when handling sam-
ple tubes and inserted them into the array using stainless
steel forceps.
Dog training procedure
Dogs were trained using a positive reinforcement ‘clicker’
technique and food rewards/praise. Initially, food rewards
were randomly hidden in one of the scent holes and the
trainer rewarded the dog for sitting or lying next to and
placing its nose on the hole. Once interested in the holes,
Stage 1 commenced in which dogs had to indicate on
single CaP urine samples placed in a random hole, with
empty test tubes in the remaining holes. The criterion
for a dog to move to the next stage was 9/10 successive
runs correct. In Stage 2, the arrays contained one CaP
sample, with the remaining holes containing different
control samples. The trainer was blind to the sample
positions and had to call out the number of the holesuspected to contain the CaP based on the dog’s choice.
The investigator, who was visually isolated, then informed
the trainer whether the choice was correct, allowing the
trainer to reward the dog appropriately. When the dog
was able to identify the scent hole containing the CaP
more frequently than expected by chance it was moved to
the formal test stage.
The number of urine samples presented to each dog
during Stages 1 and 2 varied depending on their individ-
ual rate of progress. Urine samples from different donors
were used to try to encourage the dogs to generalise on
a common cancer odour. CaP and control samples from
new donors became available in batches of 5 to 10 at in-
tervals over the training period, and it was sometimes
necessary to present urine from the same donors several
times during training. Urine samples from two or three
different donors were sometimes pooled in different
combinations to try to vary the odour profiles. Although
four scent holes were used during the testing stages,
various numbers (between three and six) were trialled
during initial training.
Testing procedure
Following training, three rigorous double-blind tests were
conducted for two dogs that showed ability to discriminate
CaP and control samples during training Stage 2. Test 1
involved dog A, a nine year-old yellow Labrador, who had
undergone approximately 5 months of training in Stages 1
and 2 prior to the test. During the test, the dog was pre-
sented with 15 arrays, each containing one CaP sample and
three controls. Each of the 15 CaP and 45 control samples
were from unique donors and were new to the dog. For
each of the 15 arrays, the position of the CaP sample in the
array (1, 2, 3 or 4) was secretly allocated using random
number lists generated remotely. This sample allocation
code was sent to the urine collection centre, where it was
used to prepare the 15 arrays of samples. The sample allo-
cation code was concealed from the investigators and dog
handlers, who did not know the position of the CaP and
controls at any point before or during the test.
During Test 1, the dog handler and dog were visually
isolated in room A (Figure 1), while the investigator placed
samples in the array. The investigator was then visually
isolated in room B and called “ready”, signalling that the
handler could enter the arena and allow the dog to sniff
the array. Once the dog had chosen a hole, the handler
rewarded the dog and called out the position in which
he/she believed the CaP sample resided (1, 2, 3 or 4).
Following a run the handler and dog moved back into
room A while the next array was prepared. An independent
referee who did not have a vested interest in the project
was present to verify the double-blinding procedure.
Tests 2 and 3 followed the same protocol except that
16 arrays of new samples were used. Test 2 again involved
Table 1 Urine samples presented during tests 2 and 3
Array number Scent hole 1 Scent hole 2 Scent hole 3 Scent hole 4
1 Age 52 Age 72 Age 64 Age 56
PSA 0.49 PSA 4.6 PSA 0.42 PSA 0.48
Gleason 6
2 Age 71 Age 51 Age 53 Age 59
PSA 7.5 PSA 0.32 PSA 0.24 PSA 0.42
Gleason 7
3 Age 62 Age 52 Age 67 Age 57
PSA 0.46 PSA 0.37 PSA - PSA 0.38
Gleason 7
4 Age 57 Age 58 Age 51 Age 50
PSA 0.21 PSA - PSA 0.39 PSA 0.35
Gleason 7
5 Age 50 Age 63 Age 66 Age 53
PSA 0.44 PSA 21.4 PSA 0.31 PSA 0.41
Gleason 7
6 Age 58 Age 54 Age 61 Age 59
PSA 0.39 PSA 0.49 PSA 7.8 PSA 0.43
Gleason 6
7 Age 60 Age 70 Age 56 Age 58
PSA 0.28 PSA 2.9 PSA 0.19 PSA 0.41
Gleason 6
8 Age 55 Age 54 Age 54 Age 67
PSA 0.41 PSA 0.43 PSA 0.21 PSA 3.4
Gleason 7
9 Age 68 Age 68 Age 68 Age 51
PSA 9.6 PSA 0.43 PSA 0.40 PSA 0.15
Gleason 7
10 Age 54 Age 53 Age 68 Age 51
PSA 0.47 PSA 0.21 PSA 0.16 PSA 6.3
Gleason 7
11 Age 58 Age 69 Age 58 Age 53
PSA 0.36 PSA - PSA 0.42 PSA 0.47
Gleason 6
12 Age 51 Age 65 Age 60 Age 60
PSA 0.44 PSA 0.23 PSA 0.23 PSA 4.0
Gleason 6
13 Age 61 Age 57 Age 62 Age 54
PSA 0.40 PSA 0.49 PSA 0.32 PSA 4.2
Gleason 7
14 Age 67 Age 64 Age 59 Age 62
PSA 9.6 PSA 0.27 PSA 0.34 PSA 0.45
Gleason 6
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Table 1 Urine samples presented during tests 2 and 3 (Continued)
15 Age 55 Age 65 Age 67 Age 57
PSA 0.38 PSA 6.4 PSA 0.46 PSA 0.38
Gleason 6
16 Age 60 Age 63 Age 55 Age 55
PSA 0.44 PSA 0.32 PSA 6.9 PSA 0.32
Gleason 6
Cancer samples are those with PSA >0.5 and Gleason score. Note the order of samples differed in Test 3.
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Stage 2 retraining following Test 1. For Test 2, an add-
itional independent referee was provided with the sample
allocation code prior to the test. Using a live speaker-phone
system this referee, who was not present at the testing
centre, was able to directly respond to the position num-
bers called out by the dog handler and immediately inform
them whether the choice was correct. Unlike Test 1, this
system allowed the dog handler to reward the dog only
for correct choices of the CaP samples whilst still ensuring
effective double-blinding.
Test 3 involved dog B, a three-year old Border Collie
with a different handler from Tests 1 and 2. This dog had
undergone approximately 5 months of training in Stages 1
and 2 prior to the test. Test 3 followed the protocol for
Test 2, except that it took place in a different testing
venue and the visually-isolated investigator informed theFigure 1 The testing arena. The dog and handler were visually
isolated in room A while the investigator inserted urine samples into
the array. The investigator then moved into room B while the
handler entered the arena and allowed the dog to sniff the array.handler whether the dog’s choices were correct or incor-
rect. Dog B was tested using 16 sets of 4 urine samples
from the same urine donors who had provided the sam-
ples for Test 2, presented in a different, randomised order.
Statistical analysis
For Tests 1 to 3, the primary outcome measure was each
dog’s overall success rate in identifying cancer urine
samples, compared with the success rate expected by
chance, i.e. 25% (four scent holes). Each test had a
power of greater than 80% to detect the difference be-
tween a dog’s success rate of 70% compared with the
success rate expected by chance, assuming a two-sided
significance level of 1%. The sensitivity and specificity
were calculated for each test and the corresponding
95% confidence intervals were calculated using a robust
variance estimate to allow for between-array variance.
Agreement between dogs A and B in Tests 2 and 3, in
which samples from the same urine donors were pre-
sented, was assessed using Cohen’s Kappa.
Ethical approval
The University of Cambridge, Department of Oncology
local ethics committee approved the study.
Results
During Stage 1, four dogs were able to locate single,
familiar CaP samples more frequently than expected
by chance (2-tailed Binomial tests, N = 10, P < 0.05),
but one of these dogs remained inconsistent. Although
time was invested in training all of the dogs at this
stage, three dogs progressed more quickly and it was
felt that the others did not have the optimum tempera-
ments for sensitive odour discrimination work. Four dogs
were too excitable and did not sniff the holes consistently
and three were insufficiently motivated to concentrate on
the task. Only three of the dogs were therefore moved to
Stage 2 of training.
During Stage 2, two of the dogs were able to discriminate
potentially familiar CaP samples from controls with the dog
handlers blind to the sample positions (2-tailed Binomial
tests: Dog A, N = 99, P < 0.0001; Dog B, N = 48, P < 0.01).
Dog A correctly chose the CaP sample in 75.8% of the
Elliker et al. BMC Urology 2014, 14:22 Page 6 of 9
http://www.biomedcentral.com/1471-2490/14/22Stage 2 runs. In the 30 runs immediately prior to Test 1
(involving CaP samples from 12 different donors), dog A
correctly chose the CaP samples on 80% of occasions. Dog
B correctly chose the CaP sample in 41.6% of Stage 2 runs
overall. In the 30 Stage 2 runs prior to Test 1, dog B cor-
rectly chose the CaP samples on 50% of occasions. These
results support the findings of other studies showing that
dogs can be trained to discriminate human urine samples.
However, because some of the urine samples were poten-
tially familiar to the dogs it could not be confirmed that a
cancer-related odour was being used for the discrimination.
On one occasion during training Stage 2 dog A was
presented with 8 new, unfamiliar CaP and 11 new, unfamil-
iar control samples. Dog A correctly identified the position
of the CaP sample in 6/8 runs (2-tailed Binomial tests,
N = 8, P = 0.034). Although this dog seemed to be dis-
criminating the samples on the basis of a cancer odour, a
double-blind test using a larger number of new, unfamiliar
samples was needed to verify the result.
During Test 1, dog A correctly indicated the position
of the CaP sample for 2/15 arrays (2-tailed Binomial test:
N = 15, P = 0.31), indicating that the dog was not dis-
criminating samples based on a cancer odour. In Test 2,
dog A correctly identified the position of the CaP sample
in 2/16 arrays (2-tailed Binomial test: N = 16, P = 0.27).
In each of these tests the sensitivity for dog A was 0.13
and specificity 0.71 (Table 2).
In Test 3, dog B correctly identified the position of
the CaP sample in 4/16 arrays (2-tailed Binomial test:
N = 16, P = 0.44), indicating that dog B was also not
discriminating the samples based on a signature cancer
odour. The sensitivity and specificity for dog B was 0.25
and 0.75 respectively (Table 2).
There was no evidence that dogs A and B were mak-
ing similar choices of urine samples in Tests 2 and 3
(kappa = −0.17, 95% CI = −0.39 to 0.05), in which samples
from the same urine donors were presented in different
orders. There was also no apparent pattern to the choices
of samples the dogs made based on the medical histories
of the urine donors that provided the samples.Table 2 Sensitivity and specificity of double-blind trials
Test (dog) Detected by dog Prostate cancer Contr
1 Yes 2 13
(Dog A) No 13 32
Total 15 45
2 Yes 2 14
(Dog A) No 14 34
Total 16 48
3 Yes 4 12
(Dog B) No 12 36
Total 16 48Discussion
Main findings
Previous studies have demonstrated that dogs may be
able to detect odours associated with cancers, but our
understanding of the best way to train and maintain
dogs for this purpose is in its early stages. In this study
we investigated the feasibility of training dogs to dis-
criminate the odour of urine from men with untreated
prostate cancer from controls, using as wide a range of
samples as it was possible to obtain from a major re-
search hospital that was carrying out a national prostate
cancer survey. During training two dogs discriminated
CaP samples from control samples more often than ex-
pected by chance, suggesting that they were recognising
a signature odour associated with CaP. However, during
three rigorously controlled double-blind tests involving
urine samples from new donors, the dogs did not indicate
CaP samples more frequently than expected by chance.
Comparison of the urine sample choices made by the dogs
in Tests 2 and 3 suggested that each dog was using differ-
ent odour cues to select the samples.
The research team and trainers were convinced of the
ability of dog A to detect a general prostate cancer odour
prior to Tests 1 and 2. This result illustrates the importance
of using extremely carefully controlled double-blind tests,
involving the presentation of only new, entirely unfamiliar
odour samples. The result does not exclude the possibility
that dogs could learn to generalise based on a common
prostate cancer odour if training was further optimised
to achieve this.
Confounding effects of multiple-sample learning
The most likely explanation for the discrepancy between
the ability of two dogs to discriminate potentially familiar
CaP samples from controls, but not unfamiliar samples,
is that the dogs memorised the odour of each individual
donor’s urine during training rather than generalise on a
common prostate cancer odour.
We did not anticipate this because we thought that the
dogs’ olfactory memory would be exceeded by the numberol Total Sensitivity (95% CI) Specificity (95% CI)
15
45
60 0.13 (0.03 to 0.42) 0.71 (0.65 to 0.77)
16
48
64 0.13 (0.03 to 0.40) 0.71 (0.65 to 0.76)
16
48
64 0.25 (0.09 to 0.52) 0.75 (0.67 to 0.82)
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be useful in informing the design of future studies to verify
how many odours a dog can remember and for how long.
Previous studies have suggested dogs can remember at
least 10 odours [17] and the minimum number of samples
dog A would have needed to remember to explain its per-
formance in Stage 2 of training was 12 CaP samples. How-
ever, the dogs may also have memorised the odours of
earlier batches of training samples (both CaP and control),
in which case the overall number of samples memorised
would have been much higher.
Had more new samples been available for training, the
dogs may eventually have exceeded the limits of their
olfactory memory, encouraging them to indicate a general
prostate cancer odour. In practice, we expended consider-
able effort on the rigorous selection of samples from a
large donor study group and it would be very difficult
to find a larger pool of urine donors. Another potential
limitation was that it was only possible to match the ages
of a proportion of control sample donors to within 5 years
of CaP donors. Finding sufficient case and control samples
to allow closer age matching, and also present enough
samples to dogs to ensure that they generalise on a disease
signature odour, may therefore always be a major limita-
tion of studies of this type. It would be even more difficult
to find sufficient donors if attempting to train dogs to
detect other, rarer cancers or medical conditions.
A recent study looking at whether lateralization occurs
in the canine olfactory system [18] could provide a possible
solution to these issues. The study found that when sniffing
novel non-aversive stimuli, dogs showed initial preferential
use of the right nostril and then a shift towards use of the
left nostril with repeated stimulus presentation. Assuming
that human urine odours/cancer odours used in reward-
based training are non-aversive to dogs, this finding may
provide a quantifiable measure of whether dogs are becom-
ing familiar with the training samples during repeated
presentation (shown by a shift towards left nostril use) or
whether they continue to perceive them as being novel
(shown by continued use of the right nostril).
Rewarding techniques during double-blind trials
The results of this study could also potentially have been
confounded because dogs are likely to have a flexible
approach to problem solving and if one strategy proves
unrewarding they may try another [19]. Dog A seemed
to be using a prostate cancer odour to select samples in
training Stage 2, but could have changed strategy during
double-blind Test 1, in which the dog was rewarded
for any choice of sample, whether CaP or control. This
raises the issue of how dogs should be rewarded during
a double-blind test. Not rewarding the dogs at all, or
rewarding them for any choice whether correct or in-
correct, could result in the dogs abandoning a strategythat no longer seems fruitful and trying alternative strat-
egies. Possible solutions are discussion in the Summary
recommendations.
Sample selection and presentation
Our control samples were selected on the basis of PSA
level, which can be a misleading indicator [20]. There
is a continuum of prostate pathology from benign hyper-
trophy through to a variety of types of established cancer,
meaning that there could have been too much overlap
between our CaP and control samples for the dogs to
decipher a common prostate cancer odour. The majority
of control donors had a PSA level <0.5 ng/ml, which
should have ensured less than a 6% chance of them
having small, clinically non-presenting prostate cancer [21].
In practice, this was the best possible control selection
criteria available to us. The alternative, using controls
of a much younger age who would be less likely to have
prostate cancer, would have introduced the additional
confounding factor of odours linked to age.
It should be noted that our sample holders did not
allow the dogs to touch the urine directly and so they
could only detect compounds volatile enough to be present
in the headspace at 37°C. In some studies [8], the dogs
could potentially make contact with the sample and
hence use their vomeronasal system to detect less volatile
compounds. This could also apply to the anecdotes of pet
dogs alerting their owners to cancer.
Number of dogs successful in initial training
Only three out of ten dogs initially recruited for the study
passed Stage 1 of training, which limited the probability of
one or more dogs successfully learning to detect prostate
cancer. High failure rates such as these are common when
training dogs for specialist roles because of the very specific
behaviour/temperament attributes required [22,23]. It is
possible that, with more time and training, more of the
dogs that were initially recruited would have reached Stage
2 of training. However, within the limited time resources
available, the research team focused efforts on training and
testing the dogs that progressed most rapidly. It has been
suggested that it may be useful to breed dogs specifically
for the purpose of cancer odour detection [24] which may
help to increase the proportion of suitable dogs available
for future studies of this type.
Summary recommendations
Based on our experiences, we make the following rec-
ommendations for future cancer-detection dog studies
(summarized in Table 3):
1. Repeat presentations of samples from the same
donors should be minimised as far as possible
during all training. Ideally, dogs should never be
Table 3 Summary of recommendations for future cancer detection dog studies
Issue Proposed solution Evidence for effectiveness of solution
Limited number of training samples from
unique donors promotes multiple sample
learning rather than odour generalisation.
Pooling of samples from different donors to
create new odour profiles.
Analytical work required to validate whether
pooling of biological samples is effective in
creating varied odour headspace.
Training dogs on several types of related disease
odours from the outset (e.g. several forms of cancer).
Some evidence for the effectiveness of this
technique based on training on two types
of cancer odour [10].
Introducing dogs to disease and control odours
concurrently from the outset of training rather than
introducing the disease odour in isolation first.
Some studies have successfully trained dogs by
presenting cancer samples in isolation in the
early stages of training. However, training on
disease and control samples from the outset may
reduce the risk of reliance on multiple sample
learning – further validation trials required.
Methods for rewarding dogs during
double-blind trials may confound
earlier training.
Independent referees should provide immediate
feedback to trainer on correct/incorrect
responses using remote system (e.g. sample
allocation code over the telephone).
Successfully employed in the present study.
Training dogs to expect a reward only for a
proportion of correct indications on positive
samples.
Widely used technique in field of psychology
and animal training.
Search-based discrimination tasks may not
be optimal for encouraging sensitive
disease odour indication behaviour.
The utility of alternative forms of discrimination
task, such as habituation-dishabituation
paradigms, should be explored.
Studies of novel paradigms for the measurement
of olfactory discrimination in dogs and others
species conducted [23].
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than once. However, in reality it may not be feasible
to gain sufficient unique samples to do this for many
types of cancer. Although our method of pooling of
samples from different donors appeared to be
unsuccessful in encouraging the dogs to generalise,
it would be useful to further explore the chemical
evidence for whether this could assist in creating
new odour profiles to widen the pool of training
samples.
2. In one study [10], dogs were successfully trained to
indicate both lung and breast cancer odours. If
different types of cancer have a common odour,
training dogs to indicate on several different types of
cancer odour in parallel may more effectively
encourage generalised cancer odour detection.
Training on several cancers would also facilitate
amassing sufficient unique samples for training. It
could also be hypothesised that some cancers may
have a ‘stronger’ odour than others and that training
dogs to indicate these cancers first may facilitate
learning to indicate a potentially ‘weaker’ prostate
cancer odour.
3. It may be that the training approach we took, in
which dogs were first trained to indicate single CaP
samples before having to learn to disregard control
samples, biased the dogs towards learning of
individual urine donors. Other studies have found
that training dogs to indicate a cancer odour in
isolation, before gradually introducing control
samples that the dog must disregard, was successful
[8]. However, we feel that if dogs are trained todisregard control samples from the outset and are
never at any stage presented cancer samples without
control samples being present, this is likely to
reduce the risk of multiple sample learning and
encourage generalisation.
4. We recommend that all future studies of cancer
detection employ a system similar to that used in
our tests, in which independent referees validate the
double-blind testing. In order to appropriately
reward dog’s choices during double-blind trials, we
also recommend employing a rewarding technique
similar to that used during Test 2, where the
independent referee provides instant feedback via
telephone as to whether the dog’s choice is correct
or incorrect.
5. Over the longer-term, and especially if dogs are ever
to be used for clinically screening large numbers of
samples of unknown disease status, fixed/variable ra-
tio reinforcement schedules may help to ensure the
odour detection behaviour is more resistant to ex-
tinction [25]. Training dogs to expect a reward only
for a proportion of correct indications on positive
samples may reduce the risk of the trained cancer
odour indication behaviour being abandoned in
favour of a new strategy.
6. All cancer detection studies to date have employed
search-based equipment that encourages dogs to
choose between different samples presented
simultaneously and indicate the one they believe most
closely matches their training odours. Although this
method may be useful for training stages, it may
not be optimal for the more selective and sensitive
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on unknown samples. Habituation-dishabituation
testing paradigms have recently been employed in
canine odour discrimination research [26] and it
may be that these techniques would provide a
more sensitive and reliable approach.
Conclusions
Some dogs learnt to accurately discriminate familiar human
urine samples based on their odours but did not generalise
to discriminate unfamiliar samples based on a signature
odour related to prostate cancer. Our study illustrates that
is it very easy to draw misleading conclusions about the
abilities of dogs to indicate certain odours, unless extremely
robust double-blind tests are conducted. Dogs may learn
to memorise odours of large numbers of specific training
samples rather than learn generalise based on a common
odour. The olfactory memory of dogs should therefore be
given careful consideration in all future studies of cancer
detection ability and training and evaluation methods
optimised to avoid any confounding effects due to multiple
sample learning.
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